Related Experiment Video
Updated: Jan 9, 2026

An Experimental Paradigm for the Prediction of Post-Operative Pain PPOP
Published on: January 27, 2010
The effect of smoking on postoperative pain and nausea, and vomiting
Hana Khalili1,2, Faridah Ihmoud1, Hammam Abdelrazeq1,2
1Department of Medicine, Faculty of Medicine and Allied Medical Sciences, An-Najah National University, Nablus, 44839, Palestine.
Background:
Postoperative pain (POP) and postoperative nausea and vomiting (PONV) are frequent and distressing complications after surgery. Smoking has been proposed as a modifiable factor influencing these outcomes, yet evidence is inconsistent and scarce from low- and middle-income countries (LMICs). We examined whether current smoking status independently predicts early POP and PONV.
Methods:
We conducted a prospective, observational study in two West Bank of Palestine tertiary referral hospitals over six months. Adults (≥ 18 years) undergoing elective surgery under general anaesthesia were included. Smoking status was self-reported (current smoker vs. nonsmoker). End-points 24 h after surgery were nausea (presence and severity on VAS), vomiting (number of episodes), and pain (presence and severity on VAS) were investigated. Logistic regression was employed to estimate adjusted odds ratios (aORs) for associations of smoking status with each outcome after adjustment for age, sex, height, weight, history of previous surgeries, history of PONV, surgical approach, duration of anaesthesia, and intraoperative opioid/antiemetic use.
Results:
Among 200 patients (90 smokers; 110 nonsmokers; median age 38 years), crude rates were: nausea 32.5% (nonsmokers 37.2% vs. smokers 26.6%), vomiting 23.1% (28.4% vs. 16.6%), and pain 87.9% (91.7% vs. 83.3%). After adjustment, smoking status was not significantly associated with postoperative nausea (aOR 1.57; 95% CI 0.64-3.86), vomiting (aOR 1.13; 95% CI 0.45-2.85), pain (aOR 0.98; 95% CI 0.29-3.23), or their severities (all p > 0.05).
Conclusion:
For this two-centre LMIC cohort study, current smoking status was not an independent predictor of early POP or PONV. Perioperative risk stratification and prevention should not solely be based on smoking status but include validated predictors (e.g., sex, history of PONV, type of procedure, duration of anaesthesia, opioid exposure). Well-powered standardised multicentre studies quantifying smoking exposure (e.g., pack-years, duration since cessation) are required.
More Related Videos
07:14A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery
Published on: January 18, 2018
05:39Author Spotlight: A Non-Intubated Video-Assisted Thoracoscopic Surgery with Multimodal Analgesia and Sevoflurane Inhalation Anesthesia
Published on: May 26, 2023
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
Two synthetic agonists of THC,...
Peripheral Artery Disease V: Postoperative Nursing Management
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
General Anesthesia: Overview
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...